Breathe Well Live Well
Lung Disease News |
FDA Rejects GSK's Breo Ellipta Asthma Therapy Use in Adolescents; Adult Use …
Lung Disease News GSK Incruse Ellipta COPD The U.S. Food and Drug Administration (FDA) ruled against the use of GlaxoSmithKline's new drug combination Breo Ellipta in asthma patients between the ages of 12 and 17. However, the Pulmonary-Allergy Drugs Advisory … |
View full post on asthma – Google News
THE Weed Blog (blog) |
Mich. Rejects Adding Autism, Asthma To Medical Pot List
CBS Local LANSING (WWJ/AP) – A Michigan panel has given the preliminary go-ahead to add post-traumatic stress disorder to the list of illnesses qualifying for medical marijuana use in the state. It would be the first addition since medical marijuana was approved … Michigan panel denies autism, asthma as eligible conditions for medical … Michigan medical marijuana panel to consider adding PTSD, autism, asthma … Medical marijuana board rejects asthma, autism as acceptable conditions |
View full post on asthma – Google News
 Medscape |
EU Committee Rejects Budesonide/Salmeterol Combo for Asthma
Medscape The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a negative recommendation on the marketing application for anti-asthma combination medication budesonide/salmeterol (Labazenit, … |
View full post on asthma – Google News
 Daily Mail |
UK's NICE rejects Novartis asthma drug in change of tack
Reuters Health ». LONDON | Thu Nov 8, 2012 7:06pm EST. LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE plans to recommend against the use of Novartis's severe asthma drug Xolair, or omalizumab, after earlier endorsing it for adults only. Now English asthma patients are denied life-changing drug offered to Scots Asthma drug life changing: swimmer |
View full post on asthma – Google News
|
UK's NICE rejects Novartis asthma drug in change of tack
Chicago Tribune LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE plans to recommend against the use of Novartis's severe asthma drug Xolair, or omalizumab, after earlier endorsing it for adults only. The National Institute for Health and Clinical … |
View full post on asthma – Google News
|
Appeals court rejects challenge to sulfur dioxide rule designed to protect …
Washington Post WASHINGTON — A federal appeals court has rejected a challenge to a tough new clean air requirement limiting sulfur dioxide emissions. The Environmental Protection Agency regulation is designed to prevent people with asthma from exposure to short-term … EPA Sulfur Dioxide Rules Upheld by US Court of Appeals Court Upholds EPA's Stricter NO2 Standards |
View full post on asthma – Google News
 CBS News |
FDA rejects petition to ban BPA in food packaging
Milwaukee Journal Sentinel … contents of many products may cause long-term health effects, including cancers of the breast, brain and testicles; lowered sperm counts, early puberty and other reproductive system defects; diabetes; attention deficit disorder, asthma and autism. Could Banning BPA Prevent Asthma? FDA Close To BPA Decision Crucial For Health Of Poor Children FDA to make decision regarding BPA |
View full post on asthma – Google News
|
NICE rejects asthma injection
Healthcare Today The NHS drug rationing body has decided that an injection for children with severe asthma is too expensive to be offered on the NHS. … |
View full post on asthma – Google News
|
UK Body Rejects Novartis Asthma Drug Xolair In Kids Under 12
Wall Street Journal … on the publicly-funded National Health Service of Novartis AG's (NVS) asthma drug Xolair for treating severely asthmatic children under the age of 12, … |
View full post on asthma – Google News
 MSN News UK |
UK's NICE Rejects Novartis' Xolair Again In Kids Aged 6 To 11
Wall Street Journal … or NICE, Thursday reiterated its earlier decision not to recommend Novartis AG's (NVS) asthma drug Xolair for children aged 6 to 11 years with severe, … Asthma rises as children return to school September marks child asthma peak Children with asthma 'at greater risk during September' |
View full post on asthma – Google News